Professor Dr med Christine Klein a renowned neurologist and neurogeneticist stands as a beacon of medical research in Lübeck Germany. Her name is synonymous with groundbreaking work on movement disorders particularly Parkinson’s disease. Right here before you stands a testament to her dedication.
Dr Klein’s journey began with medical studies in Hamburg Heidelberg and Lübeck. Her insatiable curiosity led her to internships in Stockholm Wollongong and Vitebsk. This global experience shaped her perspective broadening her understanding of neurological conditions across diverse populations.
In 1997 she embarked on a fellowship in neurogenetics at Massachusetts General Hospital and Harvard Medical School. Working under the guidance of Dr Xandra O Breakefield she delved into the molecular mechanisms of movement disorders. This experience was pivotal in shaping her research career.
Returning to Lübeck in 1999 Dr Klein continued her neurological training. She spent several summers working with the esteemed Dr Anthony E Lang in Toronto Canada. This collaboration further solidified her expertise in movement disorders particularly Parkinson’s disease.
Dr Klein’s research is truly remarkable. She identified several genetic risk factors for Parkinson’s disease. This has revolutionized the understanding of the disease’s origins. Her work on the molecular genetics of movement disorders is widely recognized. Her impact extends far beyond the lab.
In 2005 she was appointed Lichtenberg Professor at the University of Lübeck. She became Schilling Professor of Clinical and Molecular Neurogenetics in 2013. She also holds the position of Director of the Institute of Neurogenetics at the University Hospital Schleswig-Holstein. This prominent role underscores her significance.
Dr Klein’s contributions extend to leadership roles. She served as the first woman president of the German Neurological Society a position she held from 2019 to 2021. This was a significant achievement. She is also the incoming president of the European Section of the International Parkinson and Movement Disorder Society.
Her exceptional achievements have garnered numerous accolades. She is a Fellow of the European Academy of Neurology. She received the BioMedTech Prize in 2014 the C David Marsden Lecture Award in 2019 and the Cotzias Award of the Spanish Society of Neurology the same year. In 2021 she was elected to the prestigious National Academy of Sciences Leopoldina. These awards reflect her unparalleled contributions.
Dr Klein’s influence reaches far and wide. Her extensive publications further solidify her standing as a pioneer in neurology and neurogenetics. The countless students and researchers she mentored also speak volumes about her impact. This is a legacy that will continue for many years.
So here we stand before a remarkable figure. Professor Dr med Christine Klein exemplifies the spirit of dedication innovation and leadership in the field of movement disorders. Her work has significantly advanced the understanding and treatment of these complex conditions. Her presence in Lübeck is a source of pride and inspiration.